Exposure-Response (Safety) Analysis to Identify Linifanib Dose for a Phase III Study in Patients With Hepatocellular Carcinoma

Yi-Lin Chiu, Dawn M. Carlson, Rajendra S. Pradhan, Justin L. Ricker
  • Clinical Therapeutics, November 2013, Elsevier
  • DOI: 10.1016/j.clinthera.2013.09.002
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Allison M Kitten